Table 1 Clinical and immunohistochemical parameters of all the cases.
| Epithelial only (n = 10) | Biphasic (n = 14) | Monophasic (n = 10) | |
|---|---|---|---|
| Subtypes (n) | 2 adenosquamous | 10 IDC+sarcoma | |
| 8 SCC | 4 SCC+sarcoma | ||
| Age (years) | |||
| Range | 42–86 | 43–79 | 43–76 |
| Mean | 56 | 58 | 54 |
| Median | 49 | 57 | 50 |
| Tumour size (cm) | |||
| Range | 0.5–7 | 2–11.5 | 1.3–10 |
| Mean | 4.3 | 5.1 | 4 |
| Median | 3.5 | 5 | 3 |
| Nuclear grade (n) | |||
| High | 2 | 10 | 8 |
| Intermediate | 6 | 4 | 2 |
| Low | 1 | 0 | 0 |
| Oesotrogen receptor (n) | 3 | 0 | 1 |
| Progesterone receptor (n) | 2 | 0 | 1 |
| cerbB2 (n) | 3 | 0 | 2 |
| Ki‐67 (>10%, n) | 6 | 6 | 7 |
| p53 (>10%, n) | 6 | 7 | 8 |
IDC, infiltrating duct carcinoma; SCC, squamous cell carcinoma.